Clinical Trial: A Study to Evaluate the Placental Transfer of Dapirolizumab Pegol to the Infant(s) From Pregnant Study Participants With Active Systemic Lupus Erythematosus Who Are Administered Dapirolizumab Pegol

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07934472) titled 'A Study to Evaluate the Placental Transfer of Dapirolizumab Pegol to the Infant(s) From Pregnant Study Participants With Active Systemic Lupus Erythematosus Who Are Administered Dapirolizumab Pegol' on Nov. 06.

Brief Summary: The purpose of the study is to assess transfer of dapirolizumab pegol (DZP) across the placenta to infants from mothers who are administered DZP

Study Start Date: Nov. 15

Study Type: INTERVENTIONAL

Condition: Systemic Lupus Erythematosus

Intervention: DRUG: Dapirolizumab pegol (DZP)

Study participants will receive DZP at pre-specified timepoints

Recruitment Status: NOT_YET_RECRUITING

Sponsor: UCB Bioph...